Pay in 4 interest-free payments of $5.31 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Today we talk about Pfizers obesity woes, how J&J is leaning heavily into artificial intelligence, chat about how ADCs are having a heyday, and ponder the zombie microcap
De Vita F, Lauretani F, Bauer J, Bautmans I, Shardell M, Cherubini A, et al
Bloomberg similarly reported Saads view that once Aspen gets Canada registration, it can use it as a reference for many Latin American and Middle Eastern countries, and that he expects quick uptake in Canada given the high penetration of other generic drugs
FDA legalisation permits compounded alternatives to be marketed when a drug is in shortage, as semalgutide was from 2022 through early 2025
53 Under the IRAs framework, there is a fundamental incentive distortion between small molecules and biologics: Small Molecules: Subject to price negotiation 9 years after approval
Theyre not a replacement for established treatments for major depression
US$ 25.10
US$ 23.56
US$ 28.70
US$ 24.15
US$ 29.34
US$ 25.36
US$ 26.58
US$ 20.40
US$ 26.49
US$ 20.70
US$ 26.00
US$ 21.98
